Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Esperion Therapeutics, Inc. Logo
Develops and commercializes oral medicines to reduce cardiovascular risk.
United States of America
ESPR
ESSA Pharma Inc. Logo
Develops drugs targeting the androgen receptor's N-terminal domain for prostate cancer.
United States of America
EPIX
Estrella Immunopharma, Inc. Logo
Clinical-stage biopharma developing T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ESLA
Eton Pharmaceuticals, Inc. Logo
Pharmaceutical company developing and commercializing treatments for rare diseases.
United States of America
ETON
EuBiologics Co., Ltd. Logo
A biopharmaceutical company developing vaccines and offering CRMO services.
South Korea
206650
EUPRAXIA PHARMACEUTICALS INC. Logo
Clinical-stage biotech developing locally delivered, extended-release therapies.
United States of America
EPRX
eureKING Logo
A SPAC created to acquire European biomanufacturing companies.
France
KINGS
EuroAPI Logo
Develops and manufactures APIs and provides CDMO services for complex molecules.
France
EAPI
Eurobio Scientific Logo
Specializes in in vitro diagnostics for transplantation, oncology, and infectious diseases.
France
ALERS
European Institute of Science AB Logo
Develops and sells diagnostic solutions and instruments for veterinary health.
Sweden
EURI B

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.